AVE 25.0% 0.3¢ avecho biotechnology limited

media coverage, page-8

  1. 5,322 Posts.
    I would want a share of any Elixia satellite spin off....But realistically this is going to be some time off. Expansion into Asia and India for Elixia and international licensing of Body Shaper would I hope come 1st
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.